Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients

Detalles Bibliográficos
Autores principales: Faller, EM, Sugden, SM, MacPherson, PA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113013/
http://dx.doi.org/10.1186/1758-2652-13-S4-P227
_version_ 1782205868365840384
author Faller, EM
Sugden, SM
MacPherson, PA
author_facet Faller, EM
Sugden, SM
MacPherson, PA
author_sort Faller, EM
collection PubMed
description
format Online
Article
Text
id pubmed-3113013
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130132011-06-13 Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients Faller, EM Sugden, SM MacPherson, PA J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113013/ http://dx.doi.org/10.1186/1758-2652-13-S4-P227 Text en Copyright ©2010 MacPherson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Faller, EM
Sugden, SM
MacPherson, PA
Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
title Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
title_full Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
title_fullStr Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
title_full_unstemmed Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
title_short Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
title_sort therapeutics designed to neutralize soluble hiv tat protein could preserve il-7 signaling and cd8 t-cell function in hiv+ patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113013/
http://dx.doi.org/10.1186/1758-2652-13-S4-P227
work_keys_str_mv AT fallerem therapeuticsdesignedtoneutralizesolublehivtatproteincouldpreserveil7signalingandcd8tcellfunctioninhivpatients
AT sugdensm therapeuticsdesignedtoneutralizesolublehivtatproteincouldpreserveil7signalingandcd8tcellfunctioninhivpatients
AT macphersonpa therapeuticsdesignedtoneutralizesolublehivtatproteincouldpreserveil7signalingandcd8tcellfunctioninhivpatients

Ejemplares similares